Grigore Mihaela, Cruickshank Maggie E, Nieminen Pekka, Tjalma Wiebren, Moss Esther, Redman Charles
Department of Obstetrics and Gynecology, University of Medicine and Pharmacy "Grigore T. Popa" Iasi, Romania.
Aberdeen Centre for Women's Health Research, University of Aberdeen, UK.
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:46-50. doi: 10.1016/j.ejogrb.2020.10.028. Epub 2020 Oct 28.
The management of women with cervical squamous intraepithelial lesions (SIL) is fundamental to prevention of cervical cancer in an organized cervical screening programme. Clinical guidance should improve quality of care and clinical effectiveness if developed and implemented appropriately. This survey provides an update on the current situation of national guidelines for management of cervical SIL amongst member countries of European Federation for Colposcopy (EFC).
A questionnaire was sent to representatives of each member country of EFC. The questionnaire contained questions on: guidelines for management of cervical SIL of the National Societies/Associations of Colposcopy or others national societies/associations including the development and the consultation processes, guidelines for management of lower genital tract diseases and the regulations in each country for colposcopy practice.
We received responses from all 34 member countries. Thirty countries reported a national guideline for management of cervical SIL that were developed by, or in conjunction with, their national societies or associations of colposcopy. In most cases there was adherence to the recommended steps for guideline development: they were developed by a multi-disciplinary group of specialists (29 countries) and society members were consulted before publication (21 countries). A small number of countries (8) reported to have guidelines for the management of lower genital tract dysplasia (e.g. vulval disease) developed by other national societies. In most countries (26) the colposcopists are obliged to follow the guidelines but this is regulated in only 6 and in 12 countries the colposcopists need to be certified by the national society of colposcopy in order to practice.
There are advances in the development and provision of country specific guidance on the management of cervical SIL. Most EFC member countries have appropriate national guidelines that were developed using a clear methodology, are updated according to progresses in the field and are accessible online to current practitioners. These guidelines support colposcopists to follow evidence-based practice and provides understanding of best practice in guideline development and access.
在有组织的宫颈癌筛查项目中,宫颈鳞状上皮内病变(SIL)女性的管理对于预防宫颈癌至关重要。如果临床指南制定和实施得当,应能提高医疗质量和临床效果。本次调查提供了欧洲阴道镜检查联合会(EFC)成员国宫颈SIL管理国家指南的最新情况。
向EFC每个成员国的代表发送了一份问卷。问卷包含以下问题:阴道镜检查国家学会/协会或其他国家学会/协会关于宫颈SIL管理的指南,包括制定和咨询过程;下生殖道疾病管理指南;各国阴道镜检查实践的规定。
我们收到了所有34个成员国的回复。30个国家报告有由其国家阴道镜检查学会或与之联合制定的宫颈SIL管理国家指南。在大多数情况下,遵循了指南制定的推荐步骤:由多学科专家小组制定(29个国家),并在发布前咨询学会成员(21个国家)。少数国家(8个)报告有其他国家学会制定的下生殖道发育异常(如外阴疾病)管理指南。在大多数国家(26个),阴道镜检查人员必须遵循指南,但只有6个国家对此进行了规范,12个国家要求阴道镜检查人员获得国家阴道镜检查学会的认证才能执业。
在宫颈SIL管理的国家特定指南的制定和提供方面取得了进展。大多数EFC成员国都有适当的国家指南,这些指南采用明确的方法制定,根据该领域的进展进行更新,并且可供当前从业者在线获取。这些指南支持阴道镜检查人员遵循循证实践,并有助于理解指南制定和获取方面的最佳实践。